Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ninan

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Journal of Affective Disorders|March 10, 2009
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?Lucile Capuron, Fiona B Fornwalt, Bettina T Knight, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 18, 2005
Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patientsN A Al-Hilali, V T Ninan, H A Al-Humoud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1985
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeysJ N Crawley, P T Ninan, D Pickar, et al.
Archives of General Psychiatry|December 1, 1983
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patientsM Linnoila, P T Ninan, M Scheinin, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 13, 2006
Does parathyroid hormone affect erythropoietin therapy in dialysis patients?Nabieh Al-Hilali, Hani Al-Humoud, Vadakethu T Ninan, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 4, 2009
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severityAndreas B Schmitt, Michael Bauer, Hans-Peter Volz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2012
A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sitesBoadie W Dunlop, Michael E Thase, Chuan-Chuan Wun, et al.
Transplantation Proceedings|August 11, 2001
Successful therapy of acute vascular rejection with combined plasma-exchange and monoclonal antibodyR K Gupta, M R Nampoory, K V Johny, et al.
Transplantation Proceedings|September 8, 2004
Profiled hemodialysis reduces intradialytic symptomsN Al-Hilali, H M Al-Humoud, V T Ninan, et al.
The Journal of Clinical Psychiatry|November 16, 2013
Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorderAnita H Clayton, Susan G Kornstein, Boadie W Dunlop, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Journal of Affective Disorders|March 10, 2009
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?Lucile Capuron, Fiona B Fornwalt, Bettina T Knight, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 18, 2005
Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patientsN A Al-Hilali, V T Ninan, H A Al-Humoud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1985
Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeysJ N Crawley, P T Ninan, D Pickar, et al.
Archives of General Psychiatry|December 1, 1983
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patientsM Linnoila, P T Ninan, M Scheinin, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 13, 2006
Does parathyroid hormone affect erythropoietin therapy in dialysis patients?Nabieh Al-Hilali, Hani Al-Humoud, Vadakethu T Ninan, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 4, 2009
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severityAndreas B Schmitt, Michael Bauer, Hans-Peter Volz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 23, 2012
A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sitesBoadie W Dunlop, Michael E Thase, Chuan-Chuan Wun, et al.
Transplantation Proceedings|August 11, 2001
Successful therapy of acute vascular rejection with combined plasma-exchange and monoclonal antibodyR K Gupta, M R Nampoory, K V Johny, et al.
Transplantation Proceedings|September 8, 2004
Profiled hemodialysis reduces intradialytic symptomsN Al-Hilali, H M Al-Humoud, V T Ninan, et al.
The Journal of Clinical Psychiatry|November 16, 2013
Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorderAnita H Clayton, Susan G Kornstein, Boadie W Dunlop, et al.
Pageof 12